Kinetics of the blood platelets in myeloproliferative disorders
Bhattacharya, D.K.
Indian Journal of Cancer 12(2): 192-198
1975
ISSN/ISBN: 0019-509X PMID: 1058833 Document Number: 86227
Document emailed within 1 workday
Related Documents
Cortelazzo, S.; Barbui, T.; Bassan, R.; Dini, E. 1980: Abnormal aggregation and increased size of platelets in myeloproliferative disorders Thrombosis and Haemostasis 43(2): 127-130Iumashkina, A.G.; Leĭtin, V.L.; Missel'vits, F.V.; Liubimova, E.V.; Bondarenko, M.F. 1982: Disorders of the hemostatic function of blood platelets in peptic ulcer complicated by hemorrhage Terapevticheskii Arkhiv 54(2): 32-35
Zehavi, J. 1975: Platelet function and endogenic metabolism, their relation to hemostasis and to clinical disorders of blood platelets Harefuah 89(10): 463-469
Shirakawa, S. 1977: Myeloproliferative disorders Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 1): 994-995
Eleftherios C. Vamvakas 2010: The Relative Safety of Pooled Whole-Blood-Derived Platelets Prepared by the Buffy-Coat Method Versus Single-Donor (Apheresis) Platelets Clinical Laboratory 56(7-8): 263-279
Saumur, J.H.; Coleman, M.L.; Larson, L.M. 1979: Hematology problem. Myeloproliferative disorders American Journal of Medical Technology 45(7): 634-637
Bhattacharya, D.K. 1976: An experimental model for the study of kinetics of circulating platelets Indian Journal of Experimental Biology 14(2): 150-154
Iseki, T. 1993: Vitamin B12 and transcobalamin in chronic myeloproliferative disorders Rinsho Byori. Japanese Journal of Clinical Pathology 41(12): 1310-1321
Tefferi, A. 1999: Introduction: overview of chronic myeloproliferative disorders Seminars in Hematology 36(1 Suppl. 2): 1-2
Landolfi, R.; Marchioli, R.; Patrono, C. 1997: Mechanisms of bleeding and thrombosis in myeloproliferative disorders Thrombosis and Haemostasis 78(1): 617-621
Taylor, K.M.; Shetta, M.; Talpaz, M.; Kantarjian, H.M.; Hardikar, S.; Chinault, A.C.; McCredie, K.B.; Spitzer, G. 1989: Myeloproliferative disorders: usefulness of X-linked probes in diagnosis Leukemia 3(6): 419-422
Tefferi, A. 2007: The recent advances in classic BCR-ABL-negative myeloproliferative disorders Clinical Advances in Hematology and Oncology: H&o 5(2): 113-115
Muratore, R.; Follana, R.; Khayati, A.; Olmer, J. 1973: Morphological abnormalities of polymorphonuclear neutrophils during myeloproliferative disorders Nouvelle Revue Francaise d'Hematologie 13(3): 376-380
Ruggeri, M.; Castaman, G.; Rodeghiero, F. 1993: Is ticlopidine a safe alternative to aspirin for management of myeloproliferative disorders? Haematologica 78(6 Suppl 2: 18-21
Bonaccorso, R.; Teresi, M.; Gebbia, V.; Tambone Reyes, M.; Tinnirello, D.; Di Marco, P.; Citarrella, P.; Mansueto, S. 1989: Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders Journal of ChemoTherapy 1(4 Suppl): 1266-1268
Kotzé, H.F.; Lötter, M.G.; Badenhorst, P.N.; Heyns, A.D. 1985: Kinetics of In-111-platelets in the baboon: I. Isolation and labelling of a viable and representative platelet population Thrombosis and Haemostasis 53(3): 404-407
Han, Z.C.; Briere, J.; Parent, D.; Abgrall, J.F.; Sensebe, L. 1988: Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders Journal of Biological Regulators and Homeostatic Agents 2(3): 119-124
Ward, H.P.; Vautrin, R.; Swasdikul, D. 1971: Effect of serum from myeloproliferative disorders on erythropoietin-sensitive stem cells Journal of Laboratory and Clinical Medicine 78(5): 849
Romano, J.; Safai, B. 1979: Pyoderma gangrenosum and myeloproliferative disorders. Report of a case and review of the literature Archives of Internal Medicine 139(8): 932-934
Russell, N.H.; Salmon, J.; Keenan, J.P.; Bellingham, A.J. 1981: Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders Thrombosis Research 22(4): 389-397